OP23 Efficacy and safety of vedolizumab SC in patients with moderately to severely active Crohn’s disease: Results of the VISIBLE 2 study
ECCO'20 Vienna
2020
OP27 Long-term safety and efficacy of risankizumab treatment in patients with Crohn’s disease: Final results from the Phase 2 open-label extension study
ECCO'20 Vienna
2020
OP28 Gene expression (GE) values in a phase 2 trial of mirikizumab in ulcerative colitis (UC) correlate better with histopathology (HP) than endoscopy (EN) and Mayo scores
ECCO'20 Vienna
2020
OP30 The interplay of microbiome dysbiosis and immune system deregulation in patients with Crohn’s disease
ECCO'20 Vienna
2020
OP31 Meta–omics reveals microbiome-driven proteolysis as a contributing factor to the severity of ulcerative colitis disease activity
ECCO'20 Vienna
2020
OP32 Mincle signalling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis and neutrophil chemotaxis in Crohn’s disease
ECCO'20 Vienna
2020
OP33 Multi-omics analysis reveals specific bio-geographical and functional characteristics in inflammatory bowel disease intestinal mucosa
ECCO'20 Vienna
2020
OP34 Whole blood profiling of T-cell-derived miRNA allows the development of prognostic models in inflammatory bowel disease
ECCO'20 Vienna
2020
OP36 Investigating the role of bioactives produced by gut bacteria to modulate immune response in inflammatory bowel disease
ECCO'20 Vienna
2020
OP37 Fibrogenesis in chronic DSS colitis is driven by an innate lymphoid cell-independent innate immune response
ECCO'20 Vienna
2020
OP38 Top-down infliximab superior to step-up in children with Moderate-to-Severe Crohn’s disease: A multicentre randomised controlled trial
ECCO'20 Vienna
2020
OP39 Treatment of ulcerative colitis With AMT-101, a novel oral interleukin-10 immunomodulatory fusion biologic that traffics across the intestinal epithelium
ECCO'20 Vienna
2020
OP40 A core transferable microbiota in responders to faecal microbiota transplant for ulcerative colitis shape mucosal T-cell immunity
ECCO'20 Vienna
2020